Vitreforo Energy and Pretending

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.001103.03.17
Date of registration and renewal:06.03.2017
Dosage form: & nbspTablets weighing 900 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes Supplements containing zinc, copper, manganese Supplements containing iron Supplements containing iodine Supplements containing selenium Supplements containing chromium
Composition: & nbspMagnesium citrate, vitamin-mineral premix (MCC, calcium carbonate, ascorbic acid, nicotinamide, iron sulfate, calcium pantothenate, zinc sulfate, biotin, sodium selenate, retinol acetate, pyridoxine hydrochloride, thiamine mononitrate, manganese sulfate, vitamin D3, riboflavin, folicum acid, copper sulfate, potassium iodide, sodium fluoride, cyanocobalamin, chromium picolinate, sodium molybdate), griffonium extract (5-HTP), taurine, L-carnitine, fibruline Instant (inulin from chicory), dry lactulose "Lactusan", caffeine, lactose, ascorbic acid, zinc citrate, rutin, gelatin food, calcium stearate.
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamins A, B1, B2, B6, B12, C, D3, PP, biotin, pantothenic acid, folic acid and trace elementsiodine, iron, copper, zinc, manganese, chromium, molybdenum, selenium), a source of routine and caffeine containing magnesium, fluorine, 5-hydroxytryptophan, taurine, L-carnitine.
Suggested Usage: & nbspAdults take 1 tablet daily with meals or after meals. Duration of admission - 1 month, if necessary, reception can be repeated.
Contraindications:Individual intolerance of dietary supplements, pregnancy, breast-feeding; Conditions in which iodine preparations are contraindicated.
Special instructions:Before use, it is recommended to consult with an endocrinologist.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding 25 ° C.
Research protocols:In exchange for a certificate of state registration № RU.77.99.88.003.E.000706.02.17 of 13.02.2017, the expert conclusion of the FBUC of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 4401 of 06.11.2015.
Recipient:Farmatera, Open CompanyFarmatera, Open Company Russian Federation
Information update date: & nbsp19.03.2017
Instructions
Up